ANDA 74995, held by Dr Reddys. Dobutamine Hydrochloride.
As of Nov 16, 2026, ANDA 74995 (Dobutamine Hydrochloride), held by Dr Reddys, was first approved by FDA on Mar 31, 1998, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 31, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dobutamine HydrochlorideEQ 12.5MG BASE/ML ยท injectable;injection | Dobutamine Hydrochloride | Discontinued |
| Dec 8, 2000 | Supplement 2Manufacturing | Approved | None posted |
| Mar 31, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters